What question did this study set out to answer?

To evaluate the analytical performance and clinical utility of a cardiac troponin T (cTnT) immunoassay compared with creatine kinase-MB (CK-MB) for diagnosing acute myocardial infarction.

June 1, 1994Clinical ChemistryOpen Access

Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction

View Full Paper

Ask AI

Bookmark

Why the study?

Does a cardiac troponin T immunoassay provide better diagnostic sensitivity and specificity for acute myocardial infarction compared to a CK-MB mass assay?

Key Points

To evaluate the analytical performance and clinical utility of a cardiac troponin T (cTnT) immunoassay compared with creatine kinase-MB (CK-MB) for diagnosing acute myocardial infarction.
Assessed analytical imprecision, detection limits, linearity, sample stability, and interference from hemoglobin, bilirubin, lipids, and heparin.
Measured diagnostic sensitivity across time intervals (0–96 hours) in 63 patients with acute myocardial infarction (cTnT cutoff: 0.1 µg/L; CK-MB cutoff: 5.0 µg/L).
Determined diagnostic specificity in a cohort of 49 non-acute myocardial infarction control patients.
The cTnT assay achieved within-run and total imprecision of 1.6% to 11.3%, an analytical sensitivity of 0.015 µg/L, and linearity up to 13 µg/L.
Clinical sensitivity for cTnT peaked at 99% at 12–24 h and 100% at 72–96 h, compared with 87% and 59% for CK-MB over the same intervals.
Diagnostic specificity among non-infarction patients was 46% for cTnT compared with 79% for CK-MB.

Structured PICO

Does a cardiac troponin T immunoassay provide better diagnostic sensitivity and specificity for acute myocardial infarction compared to a CK-MB mass assay?

Population

112 patients, comprising 63 patients with acute myocardial infarction (AMI) and 49 non-AMI patients

Intervention

Cardiac troponin T (cTnT) immunoassay (cutoff 0.1 microgram/L)

Comparator

Creatine kinase (CK)-MB mass assay (cutoff 5.0 micrograms/L and 2.5% relative index)

Outcome

Sensitivity and specificity for the diagnosis of acute myocardial infarction at various time intervals (0 to 96 hours)surrogate

Early evaluation of the cTnT immunoassay showed it to be highly sensitive for myocardial injury but less specific than CK-MB for the diagnosis of acute myocardial infarction.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

cTnT's higher sensitivity may aid early AMI detection but lower specificity cautions against standalone use; leaves open refined cutoff validation.

Cite This Study

Wu et al. (1994) studied this question.

synapsesocial.com/papers/6a7c95a95de18cf3f8fab0b0 https://doi.org/10.1093/clinchem/40.6.900

View Full Paper

Ask AI

Bookmark

Implication

cTnT's higher sensitivity may aid early AMI detection but lower specificity cautions against standalone use; leaves open refined cutoff validation.

Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider